Saturday 17 October 2026
Export MVIS’s income statement to Excel — free account
Microvision, Inc.
MVIS Technology Scientific & Technical Instruments
Microvision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, down 74.3% from fiscal 2024. In the quarter to June 2026, revenue grew 850.3%, EPS fell 84.5%, free cash flow fell 50.3% and total debt fell 43.3%, each against the same quarter a year earlier.
1.15
0.08
−6.50%
Follow MVIS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
139.11 | 187.76 | 127.18 | 38.43 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(22.23) | (14.72) | (12.02) | (5.76) | |
P/B ratio |
4.04 | 4.08 | 5.00 | 5.35 | |
Price to Tangible BV |
4.56 | 4.09 | 8.90 | 33.88 | |
EV/Sales |
101.24 | 125.43 | 97.21 | 28.80 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.57) | (2.58) | (2.47) | (1.23) | |
EV/FCF |
(4.53) | (2.55) | (2.44) | (1.21) | |
Quick Ratio |
2.50 | 2.50 | 0.91 | 0.57 | |
Current Ratio |
2.88 | 2.69 | 1.05 | 0.68 | |
Net Debt/EBITDA |
10.93 | 2.75 | 2.53 | 1.76 | |
Debt/Assets |
0.02% | 0.03% | 0.02% | 0.02% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.02 | 0.01 | 0.01 | 0.03 | |
Operating CF/Net income |
1.16 | 0.41 | 0.65 | 0.52 | |
Capex/Depreciation |
(0.04) | (0.02) | (0.03) | (0.04) | |
Interest Coverage |
(5.79) | (32.84) | (8.53) | (4.42) | |
Research and Development Expense of Revenue |
3,310.37% | 3,892.83% | 1,544.92% | 1,065.99% | |
Selling, General and Administrative Expense of Revenue |
1,670.95% | 1,428.25% | 1,017.22% | 625.32% | |
Intangible Assets out of Total Assets |
0.07 | 0.00 | 0.16 | 0.20 | |
Share Based Compensation of Revenue |
(665.15%) | (693.72%) | 105.13% | 88.53% | |
Graham Net Nets |
0.15 | 0.15 | (0.08) | (0.31) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(29.82%) | (42.15%) | (48.41%) | (109.25%) | |
Free Cash Flow Yield |
(16.07%) | (26.19%) | (31.26%) | (61.89%) | |
Revenue per Share |
0.01 | 0.01 | 0.05 | 0.07 | |
Operating CF per Share |
(0.84) | (0.85) | (0.80) | (0.86) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow per Share |
(0.84) | (0.86) | (0.81) | (0.87) | |
Cash per Share |
5.07 | 4.13 | 2.26 | 1.24 | |
Shareholders Equity per Share |
4.60 | 3.05 | 1.92 | 0.92 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.60 | 3.05 | 1.92 | 0.92 | |
Free Cash Flow |
(16.62) | (15.65) | (16.59) | (19.45) | |
Working Capital |
75.08 | 50.96 | 2.46 | (16.14) | |
Capital Expenditures |
(0.13) | (0.24) | (0.14) | (0.30) | |
Net Current Asset Value |
54.87 | 33.54 | (16.44) | (33.70) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.53 | 1.09 | 0.15 | 0.21 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.14 | 0.49 | 0.49 | 0.51 | |
Average Payables |
1.41 | 1.38 | 2.90 | 3.72 | |
Average Inventory |
6.31 | 1.52 | 3.28 | 4.89 | |
Average Assets |
119.54 | 112.14 | 113.47 | 114.61 | |
Average Common Equity |
78.29 | 52.16 | 46.37 | 48.86 |
Columns are period end dates